| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Vanessa Roldan | Q56754352 |
| P2093 | author name string | Marín F | |
| P2860 | cites work | Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus. | Q54185332 |
| Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population | Q57740582 | ||
| Plasminogen Activator Expression in Human Atherosclerotic Lesions | Q72049376 | ||
| Hemostatic function and coronary artery disease | Q72519882 | ||
| Does hypertension confer a prothrombotic state? Virchow's triad revisited | Q73382018 | ||
| Inflammation and thrombosis: the clot thickens | Q73702701 | ||
| Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension | Q77808620 | ||
| Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans | Q78149281 | ||
| Hypertension, platelets, and the endothelium: the "thrombotic paradox" of hypertension (or "Birmingham paradox") revisited | Q78945394 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo | Q31404999 | ||
| Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease | Q33613823 | ||
| The role of rheological and haemostatic factors in hypertension | Q34456731 | ||
| Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence | Q35106116 | ||
| Pharmacological modulation of platelet function in hypertension | Q35143446 | ||
| The prothrombotic state in hypertension and the effects of antihypertensive treatment | Q35181542 | ||
| Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis | Q35552418 | ||
| C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? | Q37878667 | ||
| ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time | Q38486508 | ||
| Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q39522420 | ||
| A reliable marker of endothelial cell dysfunction: does it exist? | Q40401880 | ||
| Regulation of matrix metalloproteinase activity | Q40642352 | ||
| Prospective study of endogenous tissue plasminogen activator and risk of stroke | Q41036094 | ||
| Endogenous tissue-type plasminogen activator and risk of myocardial infarction | Q41079493 | ||
| Hypo-fibrinolysis in patients with hypertension and elevated cholesterol | Q41162776 | ||
| Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1. | Q43869290 | ||
| Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol | Q43950414 | ||
| Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients | Q44493864 | ||
| Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus | Q44835478 | ||
| LIFE: losartan versus atenolol. | Q45972146 | ||
| Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. | Q51558893 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 681-683 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Journal of Human Hypertension | Q15746469 |
| P1476 | title | Are we content with lowering blood pressure alone, or should we be asking something more from the antihypertensive drugs we use?: effects of antihypertensive agents on fibrinolytic function | |
| P478 | volume | 18 |
| Q81781580 | Hypertension, aortic sclerosis and the prothrombotic state: understanding the complex interaction | cites work | P2860 |
Search more.